14-day Premium Trial Subscription Try For FreeTry Free
NYSE:RNN
Delisted

Rexahn Pharmaceuticals, Inc. Stock Predictions

$5.24
+0 (+0%)
At Close: Sep 19, 2019
Currently predicting for Mon, 6 May 2024

RNN Predictions History

4 years ago
NameNotImportant predicted that RNN for 2019-05-06 is going $6.33 (2.10%)

5 years ago
NameNotImportant predicted that RNN for 2019-05-02 is going $5.46 (-12.50%)

5 years ago
PumpTheseNumbers predicted that RNN for 2019-03-08 is going $0.580 (2.04%)

5 years ago
JS predicted that RNN for 2019-03-08 is going $0.568 (-0.07%)

5 years ago
Brian.Lee.103603 predicted that RNN for 2019-03-08 is going $1.00 (75.93%)

Rank:

5 years ago
PumpTheseNumbers predicted that RNN for 2019-02-25 is going $0.553 (6.33%)

5 years ago
JS predicted that RNN for 2019-02-25 is going $0.533 (-0.47%)

5 years ago
Gp predicted that RNN for 2019-02-25 is going $0.500 (-6.63%)

5 years ago
PumpTheseNumbers predicted that RNN for 2019-02-11 is going $0.610 (1.43%)

5 years ago
JS predicted that RNN for 2019-02-11 is going $0.589 (-1.83%)

Click to get the best stock tips daily for free!

About Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals. Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes treatments for cancer. The company’s clinical stage oncology candidates include Archexin that completed a pilot Phase IIa clinical trial for the treatment of pancreatic cancer; RX-3117, which is in Phase Ib clinical trial for the treatment of patients with solid tumors; and Supinoxin that is in Phase I clinical trial for patients wit... RNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT